About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Sarah Carter, DPhil, MA
Post-Doctoral Research Fellow
Division of Biostatistics Research

Sarah.A1.Carter@kp.org

Dr. Sarah Carter is a maternal and child health researcher and post-doctoral research fellow in the Department of Research & Evaluation. Her research interests include maternal and child health, childbirth intervention, health care access and availability, and the effect of environmental contexts on perinatal health outcomes. At Kaiser Permanente Southern California, she is working on studies concerning pre- and perinatal maternal health, environmental exposures in pregnancy, and child development.

Before ...

Featured Video

Advancing treatments through clinical trials

Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)

News

Featured Image of News Story Titled: 5 questions for … Dr. Amrita Mukherjee

5 questions for … Dr. Amrita Mukherjee

Amrita Mukherjee, PhD, MPH, is an epidemiologist in the first year of her post-doctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Her research interests include human papillomavirus-associated cancers, gynecologic cancers, comorbidities in cancer patients and survivors, and development of risk prediction models using electronic health records and cancer registry data. ...

5 questions for … Dr. Ado Rivera

Adovich (Ado) Rivera, MD, PhD, is a health services researcher in the first year of his post-doctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. His research interests include studying disparities in chronic health disease outcomes, especially for people with HIV and sexual and gender minority populations. Before joining Kaiser Permanente, ...

5 questions for … Dr. Nana Mensah

A maternal and child health epidemiologist, Nana Mensah, PhD, MPH, is in the first year of her post-doctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Through her research working with the Kaiser Permanente Southern California Pregnancy Registry, she seeks to understand how clinical guidelines and practices shape birth outcomes in ...

5 questions for … Dr. Lewei Duan

A health economist, Lewei Duan, PhD, MS, is a post-doctoral research fellow at the Kaiser Permanente Southern California Department of Research & Evaluation. She has special interests in improving health care delivery systems, specifically in maximizing health and well-being for older adults and underserved populations. Prior to her current position, Dr. Duan worked as a ...

Remdesivir may reduce hospital readmissions for COVID-19 patients

A study of Kaiser Permanente Southern California members who were hospitalized for COVID-19 identifies key factors associated with lower chances of readmission — including treatment with the medication remdesivir and delaying discharge until 10 days have passed since COVID-19 symptoms began. “This study supports a continued role for remdesivir in treating COVID-19,” said the study’s ...

Events

Featured Division

Epidemiologic Research

Our epidemiologists seek answers to important health questions with real-world clinical relevance.

Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.

Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.